IGM Biosciences Inc.

05/30/2020 | Press release | Archived content

IGM-8444 is a potent agonistic Death Receptor 5 (DR5) IgM antibody: Induction of tumor cytotoxicity, combination with chemotherapy and in vitro safety profile

Beatrice Wang, Ling Wang, Tasnim Kothambawala, Susan Calhoun, Thomas Matthew, Genevive Hernandez, Marvin Peterson, Angus Sinclair, Eric Humke, and Bruce Keyt

IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

2020 IGM ASCO E-Poster, Abstract No. 3595